Dose-Response Effect Exercise and Depression
- Conditions
- Depression
- Registration Number
- NCT06166095
- Lead Sponsor
- University of Central Florida
- Brief Summary
The present study aims to address gaps in the literature by evaluating the objectively measured dose-response relationship between exercise and depression symptoms; examining changes in resting (Brain-derived Neurotrophic Factor) BDNF from baseline to week 10 of an exercise intervention; and assessing varying exercise intensities on enjoyment, affect, and health-related quality of life in sedentary young adult college students.
- Detailed Description
This 10-week randomized single-blind controlled trial will consist of an exercise intervention and attention control condition. A two-week familiarity trial period will be followed by 8 weeks of structured exercise. Objectively measured physical activity will be remotely monitored via Fitbit to examine its effect on depressive symptoms in sedentary young adult college students.
Approximately 48 enrolled college students ages 18 - 25 will be recruited for the proposed study and randomized with a 1:1:1 allocation to one of the following conditions:
1. high-dose (HD) moderate to vigorous physical activity (MVPA) (n=16)
2. moderate-dose (MD moderate to vigorous physical activity (MVPA) (n=16)
3. a walking (W) attention control (n=16)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
- enrolled UCF college students aged 18 to 25
- mild to moderate depressive symptoms
- willing to wear a Fitbit for extended periods of time during the study
- willing to participate in moderate-to-vigorous PA
- physically able to participate in exercise safely
- under 110 lbs
- history of bad reaction to a past blood draw
- have been advised by a medical provider to not give/donate blood
- presence of anemia
- current cognitive therapy or antidepressant medication
- diagnosis of a co-occurring condition such as attention deficit hyperactivity disorder (ADHD)
- diagnosis of a serious mental illness (SMI) such as schizophrenia or bipolar disorder
- pregnant or nursing
- current smoker
- beta-blocker medications
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Brain-derived Neurotrophic Factor (BDNF) assay 1 year A fasted (\> 8 hours) blood draw will be performed at baseline and post-treatment to measure resting serum BDNF levels. Serum concentrations of total BDNF will be measured with Human BDNF Human ELISA assay kits for total serum BDNF from ThermoFisher Scientific
- Secondary Outcome Measures
Name Time Method Fitbit for heart rate 1 year Heart rate (bpm.) will be collected through Fitabase from the Fitbit as the participants exercise and/ or walk.
Fitbit for physical activity data 1 year Duration of weekly physical activity (min.) data will be collected from the Fitbit activity trackers.
Trial Locations
- Locations (1)
University of Central Florida
🇺🇸Orlando, Florida, United States
University of Central Florida🇺🇸Orlando, Florida, United States